DRUG USE PATTERN AND IMPACT OF CLINICAL PHARMACIST INTERVENTION IN PRESCRIBING DRUGS FOR PATIENTS WITH ACUTE KIDNEY INJURY AT THONG NHAT HOSPITAL

Nhi Truc Y Nguyen 1 , Bach Nguyen 1 , Hien Thi Thu Pham 1 , Mai Thi Phuong Tran 1 , Quỳnh Thị Hương Bùi 1, 2 ,
1 Bệnh viện Thống Nhất image/svg+xml
2 Đại học Y Dược Thành phố Hồ Chí Minh image/svg+xml
* Tác giả liên hệ:

Thông tin bài viết

Thống kê
Lượt tải: 25 Lượt xem: 38
DOI
10.63947/bvtn.v1i5.7
Xuất bản
01-11-2025
Số Tập 1 Số 5 (2025): Thong Nhat Hospital’s 50-Year Journey - Comprehensive Healthcare and Healthy Aging
Chuyên mục
Nghiên cứu gốc
Danh mục
Nghiên cứu khoa học

Tải bài viết

PDF (Tiếng Anh)

Cách trích dẫn

1.
Nguyen NTY, Nguyen B, Pham HTT, Tran MTP, Thị Hương Bùi Q. DRUG USE PATTERN AND IMPACT OF CLINICAL PHARMACIST INTERVENTION IN PRESCRIBING DRUGS FOR PATIENTS WITH ACUTE KIDNEY INJURY AT THONG NHAT HOSPITAL. JHA [Internet]. Vietnam; 2025 tháng 11 1 [cited 2025 tháng 11 5];1(5):47–55. https://tcsuckhoelaohoa.vn/bvtn/article/view/54 doi: 10.63947/bvtn.v1i5.7
Đang tải trích dẫn...
Crossref
Scopus
Google Scholar
Europe PMC

Tóm tắt

Medication management in patients with acute kidney injury (AKI) poses numerous challenges due to the rapid fluctuations in renal function over a short period. This necessitates frequent reassessment of drug indications and dosages to ensure both treatment efficacy and patient safety. This study aimed to investigate the drug use characteristics and evaluate the effectiveness of clinical pharmacist interventions in prescribing medications for patients with AKI; A before-and-after study was conducted on inpatients diagnosed with AKI at Thong Nhat Hospital, Vietnam, during the pre-intervention period (from February 2022 to August 2022) and the intervention period (from September 2022 to March 2023). Clinical pharmacist interventions included reviewing prescriptions and providing guidance on dose adjustments for patients with AKI. Prescriptions were considered appropriate if the indications and dosages complied with drug usage guidelines and the Vietnamese National Drug Formulary. The effectiveness of the intervention was evaluated by comparing the appropriateness of prescribing between the two study periods; A total of 97 patients in the pre-intervention period and 94 patients in the intervention period were included. The proportion of patients receiving at least one drug potentially impairing kidney function in both periods was 33.5%, while 90.6% of patients were prescribed at least one drug that required dose adjustment or discontinuation in cases of renal impairment. The proportion of appropriately dosed prescriptions was higher in the intervention period compared to the pre-intervention period (94.7% vs. 84.5%, p = 0.022). However, the overall rate of appropriate prescribing did not differ significantly between the two periods (79.8% vs. 71.1%, p = 0.165); The rate of appropriate prescribing for AKI patients was relatively high. Clinical pharmacist interventions contributed to improving the appropriateness of drug dosing.

Từ khóa

Acute kidney injury characteristics of medication use appropriate prescription clinical pharmacist

Tài liệu tham khảo

  1. Rewa O, Bagshaw S. Acute kidney injury-epidemiology, outcomes and economics. Nat Rev Nephrol. 2014;10(4):193-207. doi:10.1038/nrneph.2013.282 DOI: https://doi.org/10.1038/nrneph.2013.282
  2. Mehta RL, Cerda J, Burdmann EA, et al. International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology. Lancet. 2015;385(9987):1-28. doi:10.1016/S0140-6736(15)60126-X DOI: https://doi.org/10.1016/S0140-6736(15)60126-X
  3. Kellum JA, Romagnani P, Ashuntantang G, et al. Acute kidney injury. Nat Rev Dis Primers. 2021;7:52. doi:10.1038/s41572-021-00284-z DOI: https://doi.org/10.1038/s41572-021-00284-z
  4. Naghnaghia S, Nazzal Z, Abu Alya L, et al. The association between renal impairment and polypharmacy among older Palestinian patients: a multi-center crosssectional study. BMC Prim Care. 2023;24(1):50. doi:10.1186/s12875-023-02005-9 DOI: https://doi.org/10.1186/s12875-023-02005-9
  5. Chang-Panesso M. Acute kidney injury and aging. Pediatr Nephrol. 2021;36(10):2997-3006. doi:10.1007/s00467-020-04849-0 DOI: https://doi.org/10.1007/s00467-020-04849-0
  6. Zhu X, Xue J, Liu Z, et al. The effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in critically ill patients with acute kidney injury: An observational study using the MIMIC database. Front Pharmacol. 2022 13:918385. doi:10.3389/fphar.2022.918385 DOI: https://doi.org/10.3389/fphar.2022.918385
  7. MacRae C, Mercer SW, Guthrie B. Potentially inappropriate primary care prescribing in people with chronic kidney disease: a cross-sectional analysis of a large population cohort. Br J Gen Pract. 2020;71(708):e483-e490. doi:10.3399/BJGP.2020.0871 DOI: https://doi.org/10.3399/BJGP.2020.0871
  8. Roux-Marson C, Baranski JB, Fafin C, et al. Medication burden and inappropriate prescription risk among elderly with advanced chronic kidney disease. BMC Geriatr. 2020;20:87. doi:10.1186/s12877-020-1485-4 DOI: https://doi.org/10.1186/s12877-020-1485-4
  9. Joosten H, Drion I, Boogerd KJ. Optimising drug prescribing and dispensing in subjects at risk for drug errors due to renal impairment: improving drug safety in primary healthcare by low eGFR alerts. BMJ Open. 2013;3:e002068. doi:10.1136/bmjopen-2012-002068 DOI: https://doi.org/10.1136/bmjopen-2012-002068
  10. Sukkha S, Rattanavipanon W, Chamroenwit B, et al. Quality assessment and cost saving of renal dosing recommendation by clinical pharmacists at medical wards in Thailand. Int J Clin Pharm. 2020;42(2):610-616. doi:10.1007/s11096-020-01016-1 DOI: https://doi.org/10.1007/s11096-020-01016-1
  11. Prajapati A, Ganguly B. Appropriateness of drug dose and frequency in patients with renal dysfunction in a tertiary care hospital: A cross-sectional study. J Pharm Bioallied Sci. 2013;5(2):136-40. doi:10.4103/0975-7406.111829 DOI: https://doi.org/10.4103/0975-7406.111829
  12. Antoniak KM, Szijj JV, Juurmaa J, Azzopardi LM. Inappropriate prescribing in patients with renal impairment. Journal of Pharmaceutical Health Services Research. 2022;13(2):83-88. doi:10.1093/jphsr/rmac014 DOI: https://doi.org/10.1093/jphsr/rmac014
  13. Kimura H, Yoshida S, Takeuchi M, Kawakami K. Impact of Potentially Inappropriate Medications on Kidney Function in Chronic Kidney Disease: Retrospective Cohort Study. Nephron. 2023;147(3-4):177-184. doi:10.1159/000526326 DOI: https://doi.org/10.1159/000526326

Giấy phép

© 2025 Tác giả. Xuất bản bởi Tạp chí Sức khỏe và Lão hóa.

Creative Commons License

Tác phẩm này được cấp phép theo Giấy phép Creative Commons Ghi công-Phi thương mại-Không phái sinh 4.0 Quốc tế.